Evaluation Of The Rims2 Locus As A Risk Locus For Parkinson's Disease Dementia
Tan, M.; Real, R.; Lawton, M.; Bresner, C.; Kanavou, S.; Fotynie, T.; Wood, N.; Nalls, M. A.; Williams, N.; Ben-Shlomo, Y.; Huw, M.; Grosset, D.; Hardy, J.; Shoai, M.; Morris, H. R.
Show abstract
In their recent letter entitled "Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in parkinsons disease", Liu and colleagues report that in a genome-wide analysis of progression to dementia in parkinsons disease (PD) the RIMS2 locus is a determinant of dementia in PD (1). In this study we have evaluated the nominated loci in a well-powered longitudinal clinical-genetic study of 2536 individuals in the tracking parkinsons and oxford discovery cohorts. We have not identified any association between the RIMS2 locus or other loci from the discovery phase and the development of Parkinsons dementia. further work is needed to understand the biological determinants of this important aspect of parkinsons and to guide the search for new treatments. Brief paragraph/AbstractIn their recent letter entitled "Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinsons disease", Liu and colleagues report that in a genome-wide analysis of progression to dementia in Parkinsons disease (PD) the RIMS2 locus is a determinant of dementia in PD (1). In this study we have evaluated the nominated loci in a well-powered longitudinal clinical-genetic study of 2536 individuals in the Tracking Parkinsons and Oxford Discovery cohorts. We have not identified any association between the RIMS2 locus or other loci from the discovery phase and the development of Parkinsons dementia. Further work is needed to understand the biological determinants of this important aspect of Parkinsons and to guide the search for new treatments.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Penetrance of Parkinson’s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score 96%
- Does COMT Play a Role in Parkinson's Disease Susceptibility Across Diverse Ancestral Populations? 95%
- The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians 95%
Similar papers in this journal
- Insights on Genetic and Environmental Factors in Parkinson’s Disease from a regional Swedish Case-Control Cohort 93%
- Quantitative Digitography Solves the Remote Measurement Problem in Parkinson’s disease 93%
- Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinsons Disease? 93%
Similar papers in this journal
- Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression 94%
- Amplification parameters of the alpha-synuclein seed amplification assay on CSF predict the clinical subtype of Parkinson's Disease at 10-year follow-up 93%
- Prospective role of PAK6 and 14-3-3 gamma as biomarkers for Parkinson's disease 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.